INMB
INmune Bio Inc
2.00$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -29.4% | -200.0% | – | – | – | – | -200.0% | – | +26.9% | – | |
| – | -0.5% | -5.3% | +32.1% | -26.9% | +2.2% | +18.2% | -26.1% | +94.5% | -321.0% | – | -9.3% | – | |
| – | +30.9% | -43.7% | -129.6% | – | -205.5% | – | -215.0% | – | – | – | -709.2% | – | |
| – | – | – | – | – | – | – | – | -72.7% | +265.8% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | -72.7% | -25.9% | – | – | – | |
| – | – | – | – | – | +0.0% | -100.0% | – | – | – | – | – | – | |
| – | +44.9% | +0.0% | – | -24.7% | -121.2% | – | +322.3% | -100.0% | – | -100.0% | – | – | |
| – | – | – | – | -51.0% | -608.7% | – | – | -140.2% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.